MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202441072850 A) filed by Mynvax Private Limited; and Indian Institute Of Science, Bangalore, Karnataka, on Sept. 26, 2024, for 'hemagglutinin based immunogenic polypeptides, compositions and methods thereof.'
Inventor(s) include Varadarajan, Raghavan; Srivastava, Simran; and Bhasin, Munmun.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to immunogenic polypeptides for eliciting an immune 5 response against influenza. These polypeptides are suitable for use in combination with hemagglutinin (HA)-containing influenza vaccine formulations. Also disclosed are polynucleotides encoding the polypeptides, DNA constructs, recombinant vectors, and recombinant bacterial host cells for expression. The disclosure further provides vaccine compositions comprising the immunogenic polypeptides and pharmaceutically acceptable 10 carriers. Methods for producing the vaccine composition and eliciting an immune response against influenza infection in a subject are also described."
Disclaimer: Curated by HT Syndication.
